相关实验视频
Updated: May 5, 2026

07:44
Localization of the Locus Coeruleus in the Mouse Brain
Published on: March 7, 2019
18.5K
在老龄化和阿尔茨海默病中,体和慢波睡眠之间的关系和阿尔茨海默病之间的关系
Neus Falgàs1,2,3, Núria Tort-Colet4,5, Isabel Martín-Sobrino1,2,3
1Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Fundació de Recerca Clínic Barcelona-IDIBAPS, Barcelona, Spain.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 3, 2026
概括
在阿尔茨海默氏症 (AD) 患者中,心脏位置 (LC) 完整性和周血管空间 (PVSs) 影响慢波睡眠 (SWS). 较高的LC完整性和较低的PVS负担改善了SWS,性别影响了这些效应.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 睡眠障碍,特别是慢波睡眠 (SWS) 的丧失,在阿尔茨海默病 (AD) 中很普遍.
- 对于阿尔茨海默病中SWS变化的神经生物学基础仍然不太清楚.
- 在SWS变化中,调查coeruleus位置 (LC) 在SWS变化中的作用至关重要.
研究的目的:
- 检查在阿尔茨海默氏病 (AD) 连续体中, (LC) 完整性和SWS之间的关系.
- 确定性别和周血管空间 (PVS) 是否改变LC完整性和SWS之间的关联.
- 探索老龄化和AD中睡眠障碍的神经生物学基础.
主要方法:
- 在一组跨越控制,轻度认知障碍和AD痴呆症的队列中利用了多重睡眠和LC敏感磁共振成像.
- 评估基底和中心半圆周血管空间 (PVSs) 和脑脊液的诺亚丁氨酸水平.
- 采用多变量线性回归,根据相关的人口,疾病和药物变量进行调整.
主要成果:
- 较大的LC完整性与缓慢波活动和缓慢振荡功率的增加相关,特别是在女性中.
- 较高的基底质PVS负担与减少的SWS光谱功率有关.
- 大脑脊髓液中诺亚上腺素水平与SWS没有显著的关联.
结论:
- 临终结核完整性,性别和PVS负担与老化和AD中的SWS变化有显著的关联.
- 这些发现突显了针对恢复性睡眠机制作为阿尔茨海默病治疗策略的潜力.
- 了解这些神经生物学联系可能会为新的干预措施铺平道路,以减轻神经退行性疾病中的睡眠障碍.
相关概念视频
Sleep-Wake Cycles
3.0K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.0K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

